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The urine of healthy man and experimental ani-
mals contains small amounts of proteins. Protein
excretion increases in many disease states. Most
urinary proteins derive from the plasma. Research-
ers' interests and endeavors, however, have increas-
ingly focused during the past decade on a variety of
nonpiasma urinary proteins emanating from tissues
and organs. They do not pertain to and are immuno-
chemically not identical with the plasma proteins
proper [1]. They are referred to as tissue anti-
gens" or "tissue constituents" because they are
serologically detected and immunohistologically lo-
calized with antitissue sera. Tissue antigens are ei-
ther organ specific or originate in tissues widely dis-
tributed in the organism, for example, in the base-
ment membranes and collagen.
As early as 1935, tissue antigens were discovered
in the urine of patients with glomerulonephritis [2].
Grant reported in 1959 on tissue constitutents of the
urogenital tract contributing to the protein of nor-
mal urine [3]. A decade later, Antoine and Neveu
emphasized the significance of altered patterns of
urinary excretion of tissue antigens in diverse path-
ologic conditions and coined the term "histuria"
[4]. Detection of tissue antigens in the urine was fa-
cilitated by the development of efficient procedures
for the production of organ-specific antisera and
sensitive qualitative and quantitative serologic
tests. Urinary tissue antigens emanate either from
the kidney and urogenital tract, being directly re-
leased into the urine, or from organs "above" the
kidney, such antigens circulating in the blood prior
to passing the glomerular filter into the urine. There
is more than one diagnostic facet to the detection of
tissue antigens in the urine. Pathologic proteinuria
is generally due to increased glomerular per-
meability or impaired tubular reabsorption. It is
possible that with the use of organ- or tissue-specific
antisera, urinary excretion of tissue constituents
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may be identified as a third source of significant pro-
teinuria. The occurrence of tissue components in
the urine may be an indicator of damage of one or-
gan or another. Thus, their detection in the urine
constitutes a simple noninvasive procedure for
diagnosing tissue injury. The persisting excretion of
these antigens, furthermore, correlates with contin-
ued activity of the underlying pathologic process.
More recently, detection of tumor-specific antigens
in the urine has been advocated as a diagnostic test
for certain forms of cancer.
The purpose of this review is to highlight some
aspects of our knowledge about the excretion of tis-
sue antigens in the urine of man and experimental
animals in health and disease.
Urinary excretion of tissue antigens of renal and
urogenital tract origin
Tissue constituents of the kidney and urogenital
tract are directly released into the urine in both nor-
mal and pathologic states. Nephric antigens may
emanate from all parts of the nephron. Urogenital
tract antigens excreted in the urine include secre-
tion products as well as cell components of the mu-
cosal surfaces and accessory genital glands.
Specific urinary proteins have been described in
the healthy rat and mouse [5, 6]. One of these, the
major urinary protein, is of alpha electrophoretic
mobility and antigenically identical with a renal pa-
renchymal constituent [7]. The major kidney anti-
gen of the rat corresponds to the major urinary pro-
tein [8]. Three of the so-called true urinary proteins
of man are antigenically identical with three com-
ponents of renal extracts [9].
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Tamm-Horsfall (TH) mucoprotein is the most ex-
tensively studied urinary protein of nephric origin
[5]. In the rat and rabbit, it is synthesized in the
proximal tubules [10, 11], but it is believed to be
produced in the distal portion of the tubules, prob-
ably in the ioops of Henle, of the human kidney [12-
19]. Four to twenty-five milligrams of TH protein
are daily excreted in the urine of healthy adult indi-
viduals. It has a molecular weight of 28 x 10G dal-
tons and is formed by the polymerization of four
equally sized molecules [15]. Under certain condi-
tions, casts of aggregated TH protein and albumin
precipitate in the renal tubules [16]. The excretion
of TH protein rises significantly with exercise [17].
It is also markedly augmented in cystic fibrosis of
the pancreas and cirrhosis of the liver [18, 19]. An
abnormal TH protein, with an increased glucose
content, is excreted in the urine of patients with the
nephrotic syndrome or chronic pancreatic disease
with glucosuria [19]. In calculous disease, the urine
contains, in addition to plasma proteins, increased
amounts of TH protein, uromucoid, and matrix sub-
stances [20, 21]. It has been assumed that matrix
substance A is unique to the matrix of kidney stones
and urine of patients with nephrolithiasis [22]. Im-
munologically, matrix substance A is identical with
renal parencymal constituents of patients with cal-
culous disease [33]. Doubt has been raised recently
as to whether matrix substance A is a single anti-
genic moiety and its occurrence indeed confined to
active formation of renal calculi [24].
A specific antigen of the brush border of the prox-
imal tubular cells is excreted in small amounts in the
urine of healthy man and rats [25, 26]. It is nephrito-
genic in as much as homoimmunization results in
autoimmune nephrosis in the rat. Urinary excretion
of specific proximal tubular antigens is increased in
a variety of experimentally induced renal diseases,
for example, toxic nephropathies, hemoglobinuric
nephrosis, and ischemic renal damage [27, 28].
Damage to the proximal tubular epithelium is the
common denominator of conditions associated with
increased excretion of kidney-specific antigens. It is
assumed that consequent on degeneration and/or
necrosis of the tubular epithelium, cellular break-
down products are released directly into the urine.
The occurrence of minute amounts of these tubular
antigens in normal urine is attributed to shedding in
the course of physiologic cellular turnover. Daily
analysis of urine samples collected from rats with
experimentally induced tubular damage reveals a
good correlation between the increased excretion of
renal antigens and continuing activity of the patho-
logic process. Once healing and repair have oc-
curred, the urine becomes devoid of nephric anti-
gens detectable by low sensitivity serologic tests
[27, 28].
Demonstration of kidney-specific antigens in the
urine is a reliable and highly sensitive indicator of
tubular damage. Thus, in experimental conditions,
in which only mild alterations or none are found by
conventional microscopy (for example, the early
stage of analgesic nephropathy [29]), nephritic an-
tigens are excreted in increased amounts; degenera-
tive changes of the proximal tubular cells occur in
rats consuming phenacetin and/or aspirin but are
detectable only under the electron microscope [29].
About one third of rats with sucrose-induced os-
motic nephrosis, characterized by hydropic degen-
eration of the proximal tubular epithelium, excrete
increased amounts of kidney antigens [27]. Rats
anesthetized with ether or pentobarbital manifest
renal histuria in the absence of overt morphologic
changes in the kidneys [30]. That renal antigens are
present in urine obtained from hydronephrotic sacs
is explicable by breakdown of tubular cells due to
mechanical vascular impairment [27].
Intorp and Milgrom have demonstrated a ther-
mostable ethanol-precipitable kidney-specific anti-
gen in the urine of calves with potassium dichro-
mate-induced acute tubular necrosis and in the
urine of a patient with acute toxic tubular necrosis
[31]; this antigen can not be detected in the normal
urine. Antigens of proximal tubular origin are ex-
creted in the urine of patients with organic mercury
poisoning (Minamata disease), chronic cadmium
poisoning, and hypokalemic nephropathy [32-34].
A plasma membrane antigen of the proximal tubular
cells has been isolated from the urine of patients
with tubular necrosis due to cephalotin-gentamycin
administration [35]. Leakage of components of the
damaged tubular epithelia contributes to the pro-
teinuria of chronic pyelonephritis in man [36]. In ex-
perimentally induced pyelonephritis, the irregular
excretion of renal antigens is consistent with the
natural evolution of this disease, characterized as it
is by exacerbations and remissions of the infec-
tious, inflammatory, and destructive processes [37].
Antigens of tubular origin are found in the urine
of glomerulonephritic patients and animals [2, 37].
Their excretion in increased amounts is attributed
to tubular damage secondary to the glomerular in-
sult. Nephric constituents are demonstrable in the
urine of rats with Masugi nephritis early in the
course of the disease, consistent with the immediate
glomerular damage ensuing from rapid binding of
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antibasement membrane antibodies in the glomeru-
lar capillary walls. In chronic serum sickness ne-
phritis, on the other hand, renal antigens appear in
the urine only alter a certain lapse of time, which
correlates with the period necessary for the formation
and deposition of circulating immune complexes in
the glomeruli [37]. Gilman in 1937 was the first to
demonstrate renal antigens in the urine of nephritic
patients [2]. Renal histuria is more pronounced in
rapidly progressive than acute glomerulonephritis
and is mild in the chronic forms of the disease [4].
Kidney antigens are, as could have been expected,
detected in the urine of patients with lupus nephri-
tis, the excretion increasing during exacerbations
and decreasing with remission [38]. Pathologic his-
tuna has also been described in hereditary nephrop-
athies and the diuretic phase following post-
operative anuria [39]. The excretion of nephric anti-
gens in the urine of recipients of renal allografts,
mainly during rejection crises, reflects tubular dam-
age. It is especially noteworthy that a positive
urinary finding oftentimes precedes the first clinical
signs of late chronic transplant rejection [40, 41].
Successful immunosupressive management is rec-
ognized by a prompt decrease in the excretion of
renal antigens, whereas persistent histuria is associ-
ated with loss of the graft [42].
The determination of certain urinary enzymes of
renal origin is but another aspect of the excretion of
kidney antigens resulting from cellular breakdown
[43]. Several tissue antigens excreted in the urine
have in fact been proven to be enzymes [44]. The
urine of rats with tubulopathies contains increased
amounts of alkaline phosphatase and aminopepti-
dase [43]. Alpha and gamma esterases, present in
the urine of man, are distinct from the blood ester-
ases and have been identified in extracts of the kid-
ney [9]; they disappear from the urine under certain
pathologic conditions [45]. The urinary concentra-
tion of lactate dehydrogenase increases in kidney
cell necrosis; the activity of this enzyme in the urine
is a measure of the extent of the disease process
[46]. Acid phosphatase and glutamin oxalacetic
transaminase increase in the urine in tubular diseases
[47]. Recently, Reitinger et al have demonstrated an
increased activity of alanin aminopeptidase, gluta-
myl transpeptidase, and alkaline phosphatase in a
tubular specific antigen in the urine of patients with
various forms of glomerulonephritis [48].
Constituents of the urogenital tract are released
directly and excreted into the urine. Grant has de-
scribed the occurrence of nonpiasma proteins in the
urine of healthy individuals; these proteins originate
in the kidney, ureter, urinary bladder, urethra, and
prostate [3]. Proteins of urinary tract origin are
found in increased amounts in the urine of patients
with acute pyelonephritis and nephrolithiasis [49].
The production of mucoproteins is augmented by
any injury to the epithelium of the renal pelvis and
lower urinary tract [50]. Fraction R3 of the non-
dialyzable material of human urine probably consti-
tutes a secretory products of the cells of the urothe-
hum and collecting tubules [50].
It was in 1933 that Bell first suggested that genital
glands contributed to the urinary protein pool [51],
a contention later confirmed by Shih [52]. The elec-
trophoretic pattern of the urinary proteins of the
male rat exhibits a peak which is absent from female
urine and blood but present in extracts of the pros-
tate [53]. The urine of normal male rats contains
two organ-specific antigens, which reside in the ac-
cessory sex glands [54]. Whereas the excretion of
these antigens is abolished by hypophysectomy,
castration, or administration of estrogen, testoster-
one medication brings about their reappearance
[55]. The excretion of these accessory sex gland an-
tigens, which are mainly of prostatic origin, is sub-
ject to considerable daily variations, probably re-
lated to the activity of the hypothalamopituitary
axis [56]. A prostate-specific phosphatase is ex-
creted in normal human urine [57, 58].
Urinary excretion of tissue antigens originating
in other organs
Tissue components emanating from organs with-
out direct contact with urine are released into the
circulation (so-called histemia) prior to being fil-
tered through the kidneys into the urine [59]. Nor-
mal human urine contains antigens particular to the
submaxillary glands and pancreas, one of the latter
having esterase activity [60]. In general, com-
ponents of organs others than those pertaining to
the urogenital system are not detectable in the urine
under physiologic conditions, their excretion in-
dicating a pathologic process in the corresponding
organ. Tissue antigens in the urine of rabbits with
hepatocellular necrosis following ligation of the
common bile duct, though detected by kidney anti-
serum, are assumed to be of hepatic origin [59]. Or-
gan-specific antigens are excreted in the urine of
rats with experimentally induced toxic hepatopa-
thies or obstructive liver disease, they are never
found in the urine of healthy animals [61]. It may be
of diagnostic significance that the antigens are de-
tectable within 1 day of the injection of hepatotoxic
agents, their excretion persists for a short while, but
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they are no longer detected when repair has set in.
With Mancini' s technique, a semi-quantitative
analysis of the excretion of hepatic constituents in
the urine of rats with thioacetamide intoxication re-
veals, first, the highest amounts within the first 24
hours and, second, a correlation between the extent
of parenchymal necrosis and the quantities of anti-
gens in the urine (Boss et al, unpublished observa-
tions). It is worthy of note that even with tech-
niques of low sensitivity, such as Ouchterlony's
test, liver antigens were detected, in the urine of
rats with only mild liver damage, as, for example,
that occurring during ether and/or pentobarbital
anesthesia [62]. Hepatic antigens are excreted in the
urine of patients with liver ailments. Hepatic his-
tuna appears to correlate neither with jaundice nor
SGOT levels but rather with the extent of paren-
chymal necrosis [63]. Interestingly, of 24 patients
with liver diseases, whose urine was tested, only
those four with hepatic histuria succumbed within a
few days of a positive urinary finding. Tissue anti-
gens have also been detected in the urine of patients
with chronic pancreatitis complicated by obstruc-
tive jaundice [4].
Testis-specific antigens are excreted in the urine
of rats with testicular necrosis induced by cadmium
chloride or temporary ligation of the spermatic ves-
sels [28]. Testicular breakdown products presum-
ably are released into the circulation prior to their
passage into the urine. There is no evidence that
they gain access directly to the urine via the vas
deferens as well. Placenta-specific antigens are
rarely discovered in the urine of normal pregnant
rats. When gestation is interfered with (for ex-
ample, by the injection of nephrotoxic serum or
endotoxin), these antigens are excreted in increased
amounts, correlating well with induced necrosis of
the giant cell layer, which harbors the placenta-spe-
cific antigens [64].
A placenta-specific protein has been described in
the urine of normal pregnant women [65]. In our
laboratory, a soluble placental antigen is consistent-
ly found in the urine of pregnant women. On the
other hand, particulate (microsomal and mitochon-
drial) antigens are generally detected only in the
urine of women with toxemia or preeclampsia; they
were demonstrated once in a patient with tropho-
blastic malignancy. A quantitative test is currently
being developed for the determination of particulate
placental antigens in the urine, the aim being the
early diagnosis of placental damage in toxemia and
other forms of placental pathology (Rosenmann and
Boss, unpublished observations).
Urinary excretion of connective tissue antigens
Connective tissue constituents are excreted in the
urine of man and experimental animals in health and
disease. They emanate from a variety of organs in
addition to being shed directly into the urine from
the kidneys and urogenital tract. Catchpole and
Engel have reported on collagen-derived molecules
in the urine of healthy rats [66], a finding confirmed
in our laboratory, using a specific antiserum to tail-
tendon collagen [67]. Rats with nephrotoxic serum
nephritis excrete increased amounts of these colla-
gen-like components [68]. The degree of collagen-
uria and glomerular damage correlate well with
each other. Increased glomerular capillary per-
meability seems to be primarily responsible for the
augmented excretion of collagenous molecules,
which are physiologically present in the circulation,
though enhanced turnover or breakdown of inter-
stitial collagen may play an important role as well.
Patients with bone diseases, for example, Paget's
disease, excrete large amounts of polypeptides rich
in hydroxyproline [69, 70]. These macromolecules,
which probably derive from collagen, are present in
small amounts in normal urine. Their increased ex-
cretion is believed to be due to the enhanced syn-
thesis and rapid degradation of collagen or the fail-
ure of incorporating newly formed subunits into the
tropocollagen molecule.
Ground substance components are found in the
urine. Forty years ago, Parfentjew and Perlzweig
suspected that some urinary proteins were related
to the chondromucoids [71]. More recently, Boyce,
King, and Fielden have suggested that fraction Ri
of the nondialyzable urinary solids derives from
ground substance [72]. Increased amounts of muco-
proteins, believed to originate from the ground sub-
stance, are excreted in the urine of rats exposed to
X-irradiation or dosed with parathyroid extract [73-
75]. This is indicative of damage to or enhanced me-
tabolism of the ground substance and release into
the circulation of soluble glycoprotein moieties
from dissolving bone matrix. Similarly, urinary mu-
coproteins are increased in human hyperparathy-
roidism and conditions seemingly associated with
rapid turnover of ground substance, such as febrile
states, hyperthyroidism, collagen diseases, and cor-
ticosteroid therapy [76].
Basement membrane (BM) constituents excreted
in the urine may emanate from the normal extra-
cellular membranes of the glomeruli, as well as from
all other organs of the body. Two glomerular BM
(GBM) antigens are present in low concentrations
in the urine of healthy man and rabbit, but only one
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has been found in the urine of the rat [77—79]. The
GBM antigens are possibly nephritogenic, it being
speculated that their tubular reabsorption may initi-
ate an anti-GBM-mediated glomerulonephritis [80].
Urinary BM antigens probably are not solely of gb-
merular origin, because similar moieties are widely
distributed in mesenchymal and epithelial basement
membranes of all organs [81]. The glomeruli, how-
ever, are apparently their main source, because the
GBM are continuously catabolized and replaced in
their entirety every 30 to 60 days [82, 83]. Four
GBM antigens are found in the urine of rabbits with
nephrotoxic serum nephritis. The excretion of the
two additional GBM antigens is thought to be due to
the effects of granulocytic proteolytic enzymes on
the glomerular capillary wall [84]. In rats with neph-
rotoxic serum nephritis, there is a marked increase
in the urinary GBM excretion with progression of
the disease [85]. The amounts of soluble GBM anti-
gens also increase in the urine of patients with
glomerulonephritides, nephrotic syndrome of child-
hood, congenital nephrotic syndrome (Finnish
type), Alport's syndrome, and pyelonephritis. A
correlation between the excretion of GBM antigens
and the activity of the underlying disease process is
noteworthy. The augmented excretion of BM anti-
gens in kidney diseases reflects increased per-
meability of the glomerular filter, but is primarly a
manifestation of the abnormal metabolism, in-
creased turnover, and/or breakdown of the GBM.
Urinary excretion of tissue antigen associated with
neoplasia
Proteinuria in cancer patients is a well-recognized
occurrence. It is rarely a symptom of a glomerulop-
athy, such as an immune complex nephritis devel-
oping consequent on an antitumor immune re-
sponse [921. Urinary tissue proteins may originate
from peritumoral tissues which are being destroyed
by the neoplastic process [93], or may consist of
cancerous constituents, liberated in excess because
of an increased turnover and/or necrosis of neo-
plastic cells [94]. The carcinoembryonic antigen
(CEA) or CEA-like molecules are excreted in small
amounts under normal conditions, whereas in-
creased amounts are present in the urine of about
one half of patients with urothelial carcinoma [95,
96], the urinary CEA being shed directly into the
urine rather than filtered through the kidneys [97].
Urinary CEA levels are of great value in the post-
operative follow-up of bladder cancer patients
[108]. Raised urinary CEA levels are, however, also
encountered in patients with urinary tract infections
[98, 99]. Expectedly, augmented urinary excretion
of CEA has been described in patients with neo-
plasms of other organs, which are associated with
raised serum CEA titers [100].
Alpha-fetoprotein (AFP) is detectable in the urine
of rats with hepatocellular carcinoma [101]. It is of
especial note that in animals on a hepatocarcinogen-
ic regimen the urine turns positive prior to micro-
scopic evidence of tumorigenesis [102]. It should be
further emphasized that AFP is not synthesized ex-
clusively by neoplastic liver cells. It is easily de-
monstrable in the urine of rats with toxic hepatopa-
thies of diverse origin [103, 104]. In agreement with
other investigative approaches, AFP is detected
less frequently in the urine of rats whose livers ex-
hibit extensive necrosis and inflammation than it is
in those who hepatic lesions are in the regenerative
phase. The excretion of AFP in the urine of hepa-
toma patients has been confirmed by Cohen, Star-
kovs, and Olweney [105].
The occurrence of tumor-specific antigens in the
urine is well established. Antigens specific for mela-
noma, neuroblastoma [106], and bladder cancer
have thus far been identified in the urine of patients
[107, 108]. Furthermore, human tumor-associated
antigens are found in the urine of patients with large
localized sarcomas. The urine becomes nonreactive
after surgical ablation of the tumor and the urinary
antigens reappear with tumor recurrence [109]. The
concentration of the so-called polypeptide antigen
is high in the urine of most patients with malignant
neoplasms and of some patients with benign tumors
[110].
Concluding remarks
Antigens emanating from various organs and tis-
sues are excreted under normal and pathologic con-
ditions, contributing to the urinary protein pool.
Tissue components of the kidney and urogenital
tract are shed directly into the urine. Tissue anti-
gens of organs "above the kidney" circulate in the
blood prior to being filtered through the kidneys.
Antigens of the connective tissue (that is, collagen,
basement membrane, and ground substance) pass
into the urine by either route. Tumor antigens also
gain access to the urine by either pathway, depend-
ing on the site of the neoplasm. Tissue antigens in
the normal urine are probably a reflection of the
physiological processes of tissue turnover and me-
tabolism. Their increased excretion under patholog-
ic conditions results from necrosis, cell breakdown,
and/or increased turnover of the involved tissue. In
neoplastic states, the excretion of constituents of
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the tumor and/or peritumoral tissues may contrib-
ute to proteinuria. It should be noted that in certain
diseases excretion of tissue antigens, physiological-
iy present in the urine, decreases or disappears,
whereas in other conditions tissue antigens appear
de novo in the urine. The urinary excretion of organ-
specific antigens lasts as long as the underlying
pathologic process persists and disappears con-
comitantly with repair and healing of the tissue
damage. Therefore, repeatedly tested urine speci-
mens during follow-up examination may be of aid in
the evaluation of disease activity. The occurrence
of certain tissue antigens in the urine is a reliable
and sensitive indicator of organ damage, but is is as
yet of no value in establishing an etiologic diagno-
sis. Future research will disclose whether some pat-
terns of urinary organ-specific antigen are charac-
teristic for one entity or another.
A battery of specific antisera to various organs,
tissues, and neoplasms used for urinalysis would
enable the detection, by a simple noninvasive proce-
dure, of organ damage or a neoplastic process. The
application of immunologic techniques using these
antisera may provide the laboratory with easy and
reliable screening tests for determining organ
damage and neoplasms, activity of the underlying
process, as well as results of therapy.
Reprint requests to Dr. E. Rosenmann, Department of Pathol-
ogy, Hadassah University Hospital, Mount Scopus, Jerusalem,
Israel
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